Taylor, Ronald P., Lindorfer, Margaret A., Cook, Erika M., Beurskens, Frank J., Schuurman, Janine, Parren, Paul W.H.I., Zent, Clive S., VanDerMeid, Karl R., Burack, Richard, Mizuno, Masashi and Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676 2017. Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9. Clinical Immunology 181 , pp. 24-28. 10.1016/j.clim.2017.05.016 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (517kB) | Preview |
Abstract
We examined complement-dependent cytotoxicity (CDC) by hexamer formation-enhanced CD20 mAb Hx-7D8 of patient-derived chronic lymphocytic leukemia (CLL) cells that are relatively resistant to CDC. CDC was analyzed in normal human serum (NHS) and serum from an individual genetically deficient for C9. Hx-7D8 was able to kill up to 80% of CLL cells in complete absence of C9. We conclude that the narrow C5b-8 pores formed without C9 are sufficient for CDC due to efficient antibody-mediated hexamer formation. In the absence of C9, we observed transient intracellular increases of Ca2 + during CDC (as assessed with FLUO-4) that were extended in time. This suggests that small C5b-8 pores allow Ca2 + to enter the cell, while dissipation of the fluorescent signal accompanying cell disintegration is delayed. The Ca2 + signal is retained concomitantly with TOPRO-3 (viability dye) staining, thereby confirming that Ca2 + influx represents the most proximate mediator of cell death by CDC.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Publisher: | Elsevier |
ISSN: | 1521-6616 |
Date of First Compliant Deposit: | 13 July 2017 |
Date of Acceptance: | 19 May 2017 |
Last Modified: | 05 May 2023 13:50 |
URI: | https://orca.cardiff.ac.uk/id/eprint/102333 |
Citation Data
Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |